胸膜肺炎放线杆菌五重缺失突变株SLW07(ΔapxICΔapxIICΔorf1ΔcpxARΔarcA)的制备、安全性与免疫原性
在胸膜肺炎放线杆菌四重缺失突变株SLW06(血清型1)基础上灭活毒力决定因子ArcA,构建五重缺失突变株SLW07。SLW07对宿主细胞的黏附和侵袭较亲本株SLW06减弱,更易被RAW264.7巨噬细胞吞噬和清除,对小鼠毒力更低;免疫试验显示SLW07与SLW06均优先刺激小鼠2型辅助性T细胞应答,SLW07在ArcA突变后保护性免疫未受影响,小鼠免疫后可完全抵抗强毒株攻击。
要点
- SLW07较亲本株SLW06对宿主细胞黏附和侵袭减弱,更易被RAW264.7巨噬细胞吞噬清除。
- SLW07对小鼠毒力低于亲本株SLW06。
- SLW07与SLW06均优先刺激小鼠2型辅助性T细胞应答,SLW07保护性免疫未受ArcA突变影响。
核心结论
- SLW07是进一步减毒且与四重缺失亲本SLW06保护效力相似的候选活疫苗。
研究设计与样本
- 在胸膜肺炎放线杆菌四重缺失突变株SLW06(ΔapxICΔapxIICΔorf1ΔcpxAR,血清型1)基础上灭活毒力决定因子ArcA,构建五重缺失突变株SLW07。
- 开展SLW07与亲本株SLW06的黏附侵袭、RAW264.7巨噬细胞吞噬清除、小鼠毒力及免疫原性试验。
主要发现
- SLW07对宿主细胞的黏附和侵袭较亲本株SLW06减弱。
- SLW07较亲本株SLW06更易被RAW264.7巨噬细胞介导的吞噬和清除。
- SLW07对小鼠的毒力低于亲本株SLW06。
- SLW07和SLW06均优先刺激小鼠2型辅助性T细胞应答。
- 活疫苗诱导脾淋巴细胞产生白细胞介素-6和肿瘤坏死因子-α。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We inactivated a virulence determinant, ArcA, in an Actinobacillus pleuropneumoniae quadruple deletion mutant SLW06 (ΔapxICΔapxIICΔorf1ΔcpxAR, serovar 1), and a quintuple deletion mutant SLW07 was generated. SLW07 showed decreased adherence to and invasion of host cells, compared to its parent strain SLW06. SLW07 was more sensitive in RAW264.7 macrophage-mediated phagocytosis and clearance. SLW07 was less virulent in mice. An immunization assay indicated that both SLW07 and SLW06 preferentially stimulated T helper cell type 2 response in mice. Live vaccines induced the production of interleukin-6 and tumor necrosis factor-α by splenic lymphocytes. Furthermore, the protective immunity of SLW07 was not affected after ArcA mutation. Immunization with SLW07 could provide a complete protection following virulent A. pleuropneumoniae challenge in mice. Our results suggest that SLW07 is a promising live vaccine candidate, which is further attenuated from and shares similar protective efficacy with its quadruple deletion parent SLW06.
引用
- Yuan F, Liu J, You W, et al. Generation, safety and immunogenicity of an Actinobacillus pleuropneumoniae quintuple deletion mutant SLW07 (ΔapxICΔapxIICΔorf1ΔcpxARΔarcA). Vaccine. 2018. PMID: 29486946. doi:10.1016/j.vaccine.2018.02.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。